What's new? Log in Free sign up

Regulus Therapeutics (RGLS) News and press releases

Company Profile

News

From Benzinga Pro

Stocks That Hit 52-Week Lows On Monday

On Monday, 198 companies hit new 52-week lows.

12 Health Care Stocks Moving In Friday's After-Market Session

Earnings Scheduled For March 9, 2023

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is expected to report earnings for its fourth quarter.

Earnings Outlook For Regulus Therapeutics

12 Health Care Stocks Moving In Tuesday's After-Market Session

Sanofi Opts To Terminate Rare Disease Program With Regulus Therapeutics

Biotech, Large Cap, News, Penny Stocks, Health Care, Contracts, General

Press releases

From Benzinga Pro

Regulus Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Recent Updates

Earnings, Press Releases

Enrollment progressing in Phase 1b Multiple-Ascending Dose (MAD) study of RGLS8429 in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) Top-line data in the first cohort of RGLS8429-treated ADPKD

Regulus Therapeutics to Present at the SVB Securities Global Biopharma Conference

SAN DIEGO, Feb. 9, 2023 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or

Regulus Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Jan. 13, 2023 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.